Related Experiment Video

Updated: Jun 8, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Synthetic lethal screen of an EGFR-centered network to improve targeted therapies

Igor Astsaturov1, Vladimir Ratushny, Anna Sukhanova

  • 1Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Science Signaling
|September 23, 2010
PubMed

Insights

Developing targeted cancer therapies is challenging due to drug resistance. This study identified protein networks linked to the epidermal growth factor receptor (EGFR) that, when targeted, can overcome resistance and improve treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cellular resistance mechanisms limit the effectiveness of targeted cancer therapies.
  • Synthetic lethal screens suggest gene networks near therapeutic targets influence drug resistance.

Purpose of the Study:

  • To identify proteins regulating resistance to epidermal growth factor receptor (EGFR)-targeted agents and non-specific cytotoxic agents.
  • To explore the potential for combination therapies by targeting proteins within the EGFR network.

Main Methods:

  • Developed a protein network centered on EGFR.
  • Utilized small interfering RNA (siRNA) screening to probe the EGFR network for resistance determinants.
  • Investigated drug synergy within identified subnetworks.

Main Results:

  • Identified specific protein subnetworks that influence resistance to cancer therapeutics.
  • Found that proteins interacting with the core EGFR network are enriched for resistance determinants.
  • Demonstrated that targeting connected proteins (e.g., PKC, Aurora A, STAT3) synergizes with EGFR antagonists.

Conclusions:

  • Targeting proteins within the EGFR network can overcome drug resistance.
  • Combination therapies involving EGFR antagonists and drugs targeting connected proteins show promise for clinical application.
  • This focused approach can enhance the rational design of combination cancer treatments.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...